Hennessy BT - Search Results

1

Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line set.

Park ES, Rabinovsky R, Carey M, Hennessy BT, Agarwal R, Liu W, Ju Z, Deng W, Lu Y, Woo HG, Kim SB, Cheong JH, Garraway LA, Weinstein JN, Mills GB, Lee JS, Davies MA. Park ES, et al. Among authors: hennessy bt. Mol Cancer Ther. 2010 Feb;9(2):257-67. doi: 10.1158/1535-7163.MCT-09-0743. Epub 2010 Feb 2. Mol Cancer Ther. 2010. PMID: 20124458 Free PMC article.

2

Exploiting the PI3K/AKT pathway for cancer drug discovery.

Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. Hennessy BT, et al. Nat Rev Drug Discov. 2005 Dec;4(12):988-1004. doi: 10.1038/nrd1902. Nat Rev Drug Discov. 2005. PMID: 16341064 Review.

3

Identification of remodeling and spacing factor 1 (rsf-1, HBXAP) at chromosome 11q13 as a putative oncogene in ovarian cancer.

Hennessy BT, Nanjundan M, Cheng KW, Nolden L, Mills GB. Hennessy BT, et al. Eur J Hum Genet. 2006 Apr;14(4):381-3. doi: 10.1038/sj.ejhg.5201570. Eur J Hum Genet. 2006. PMID: 16418735 No abstract available.

4

Ovarian cancer: homeobox genes, autocrine/paracrine growth, and kinase signaling.

Hennessy BT, Mills GB. Hennessy BT, et al. Int J Biochem Cell Biol. 2006;38(9):1450-6. doi: 10.1016/j.biocel.2006.01.009. Epub 2006 Feb 21. Int J Biochem Cell Biol. 2006. PMID: 16682246 Review.

5

Molecular screening for breast cancer prevention, early detection, and treatment planning: combining biomarkers from DNA, RNA, and protein.

Stemke-Hale K, Hennessy B, Mills GB, Mitra R. Stemke-Hale K, et al. Curr Oncol Rep. 2006 Nov;8(6):484-91. doi: 10.1007/s11912-006-0078-5. Curr Oncol Rep. 2006. PMID: 17040626 Review.

6

Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells.

Tibes R, Qiu Y, Lu Y, Hennessy B, Andreeff M, Mills GB, Kornblau SM. Tibes R, et al. Mol Cancer Ther. 2006 Oct;5(10):2512-21. doi: 10.1158/1535-7163.MCT-06-0334. Mol Cancer Ther. 2006. PMID: 17041095

7

Point mutations of protein kinases and individualised cancer therapy.

Davies M, Hennessy B, Mills GB. Davies M, et al. Expert Opin Pharmacother. 2006 Nov;7(16):2243-61. doi: 10.1517/14656566.7.16.2243. Expert Opin Pharmacother. 2006. PMID: 17059381 Review.

8

The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis.

Liang J, Shao SH, Xu ZX, Hennessy B, Ding Z, Larrea M, Kondo S, Dumont DJ, Gutterman JU, Walker CL, Slingerland JM, Mills GB. Liang J, et al. Nat Cell Biol. 2007 Feb;9(2):218-24. doi: 10.1038/ncb1537. Epub 2007 Jan 21. Nat Cell Biol. 2007. PMID: 17237771

9

Non-parametric quantification of protein lysate arrays.

Hu J, He X, Baggerly KA, Coombes KR, Hennessy BT, Mills GB. Hu J, et al. Among authors: hennessy bt. Bioinformatics. 2007 Aug 1;23(15):1986-94. doi: 10.1093/bioinformatics/btm283. Epub 2007 Jun 28. Bioinformatics. 2007. PMID: 17599930

10

A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.

Berns K, Horlings HM, Hennessy BT, Madiredjo M, Hijmans EM, Beelen K, Linn SC, Gonzalez-Angulo AM, Stemke-Hale K, Hauptmann M, Beijersbergen RL, Mills GB, van de Vijver MJ, Bernards R. Berns K, et al. Among authors: hennessy bt. Cancer Cell. 2007 Oct;12(4):395-402. doi: 10.1016/j.ccr.2007.08.030. Cancer Cell. 2007. PMID: 17936563 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

213 results

Search Page

Filters